Although there was no association between the expression of IL-9 and its receptor, IL-9R, and the clinical characteristics, IL-9 production in CD8+ T-cells from patients with BC was higher than in the healthy controls with more expression in IL-9RHiCD8+ T-cells. The gene discussed is CD8A; the disease is breast cancer.